PubRank

Minoru Nakamura

Author PubWeight™ 54.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 2005 4.29
2 Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int 2006 1.40
3 Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol 2010 1.13
4 Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int 2006 1.12
5 [Two cases of spinal arteriovenous malformation presenting with subarachnoid hemorrhage]. No Shinkei Geka 2004 1.09
6 Detection of human herpesvirus-8 in peripheral blood mononuclear cells from adult Japanese patients with multicentric Castleman's disease. Br J Haematol 2003 1.08
7 Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases. Hepatology 2005 1.08
8 Liver architecture, cell function, and disease. Semin Immunopathol 2009 1.06
9 CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 2008 1.04
10 Toll-like receptor expression in lupus peripheral blood mononuclear cells. J Rheumatol 2007 1.04
11 Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol 2006 1.04
12 Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology 2008 1.03
13 Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease. Transl Res 2008 1.02
14 Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology 2003 1.02
15 Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett 2008 1.01
16 Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. Lab Invest 2005 1.00
17 Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study). Liver Int 2011 0.97
18 Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun 2005 0.96
19 Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 2003 0.92
20 Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells. Life Sci 2005 0.89
21 Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts. Arthritis Res Ther 2012 0.88
22 Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest 2010 0.88
23 Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection. J Hepatol 2006 0.87
24 Elevated serum BAFF levels in patients with autoimmune hepatitis. Hum Immunol 2007 0.87
25 Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis. Liver Int 2013 0.87
26 Risk factors and prediction of long-term outcome in primary biliary cirrhosis. Intern Med 2011 0.86
27 Serum BAFF and APRIL levels in patients with PBC. Clin Immunol 2009 0.85
28 Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients. J Gastroenterol 2013 0.84
29 Lipopolysaccharide signaling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitro. FEBS Lett 2004 0.84
30 Suppression of anoikis by v-Src but not by activated c-H-ras in human gallbladder epithelial cells. Cell Biol Int 2003 0.84
31 Expression of microsomal prostaglandin E synthase-1 in human hepatocelluar carcinoma. Liver Int 2007 0.83
32 CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes. Arthritis Res Ther 2011 0.83
33 Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. J Hepatol 2010 0.83
34 Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synovium. J Rheumatol 2011 0.83
35 Human primary biliary cirrhosis-susceptible allele of rs4979462 enhances TNFSF15 expression by binding NF-1. Hum Genet 2015 0.82
36 Peroxynitrite-mediated matrix metalloproteinase-2 activation in human hepatic stellate cells. FEBS Lett 2005 0.82
37 Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. J Gastroenterol 2011 0.82
38 T cell immunity and primary biliary cirrhosis. Autoimmun Rev 2003 0.81
39 Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients. J Gastroenterol 2013 0.81
40 Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis. Hepatology 2008 0.81
41 The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population. PLoS One 2013 0.80
42 Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis. J Immunol 2007 0.80
43 A polymorphism in the integrin αV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients. J Gastroenterol 2010 0.79
44 Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. J Autoimmun 2003 0.79
45 FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts. Immunol Lett 2004 0.79
46 Protection against methotrexate toxicity by a soybean protein- and omega-3 fatty acid-containing diet: comparative study with a casein-containing diet. Oncol Rep 2004 0.78
47 Idiopathic portal hypertension associated with systemic sclerosis and Sjögren's syndrome. Clin Rheumatol 2005 0.78
48 Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes. Rheumatology (Oxford) 2009 0.78
49 Inhibitory effects of the JAK inhibitor CP690,550 on human CD4(+) T lymphocyte cytokine production. BMC Immunol 2011 0.78
50 Association of STAT4 polymorphisms with susceptibility to type-1 autoimmune hepatitis in the Japanese population. PLoS One 2013 0.77
51 Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes. Mod Rheumatol 2012 0.77
52 Human intrahepatic biliary epithelial cell as a possible modulator of hepatic regeneration: Potential role of biliary epithelial cell for hepatic remodeling in vivo. Hepatol Res 2007 0.77
53 Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver. Med Sci Monit 2012 0.77
54 Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study. J Gastroenterol 2010 0.77
55 Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus. Metabolism 2006 0.77
56 HLA-DRB1*04 alleles in Japanese rheumatoid arthritis patients with AA amyloidosis. J Rheumatol 2006 0.76
57 Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis. J Clin Immunol 2012 0.76
58 HLA-DP gene polymorphisms and hepatitis B infection in the Japanese population. Transl Res 2012 0.76
59 Clinicopathological significance of serum fractalkine in primary biliary cirrhosis. Dig Dis Sci 2013 0.75
60 Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis. Acta Med Okayama 2015 0.75
61 Chronologic changes of explanted liver volume and the use of ursodeoxycholic acid in patients with end-stage primary biliary cirrhosis. Hepatol Res 2014 0.75
62 [A case report of Lhermitte-Duclos disease with systematic AVMs]. No To Shinkei 2003 0.75
63 IgA class antibodies to 2-oxo-acid dehydrogenase complex are not predictive markers of histopathological progression in primary biliary cirrhosis. Autoimmunity 2006 0.75
64 Retracted 3-benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis. Bioorg Med Chem 2011 0.75
65 [Autoimmune liver diseases and related afflictions--factors responsible for their development]. Nihon Naika Gakkai Zasshi 2006 0.75
66 Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer. Cancer Chemother Pharmacol 2005 0.75
67 [Recent topics on PBC. Discussion]. Nihon Shokakibyo Gakkai Zasshi 2013 0.75
68 Acute hepatitis in a patient with familial Mediterranean fever. Liver Int 2007 0.75
69 [A case of moyamoya disease diagnosed by cerebral ischemic symptoms induced by anti-hypertensive therapy]. No Shinkei Geka 2003 0.75
70 Slowly progressive insulin-dependent diabetes in a patient with primary biliary cirrhosis with portal hypertension-type progression. Intern Med 2012 0.75
71 [A case of atypical meningioma associated with acute deterioration and cerebral herniation]. No Shinkei Geka 2003 0.75
72 Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report. Bull Tokyo Dent Coll 2013 0.75